Phillip B. Stott
About
In The Last Decade
Phillip B. Stott
10 papers receiving 326 citations
Peers
Comparison fields: 5 of 56
- Oncology 207
- Pathology and Forensic Medicine 129
- Genetics 113
- Public Health, Environmental and Occupational Health 79
- Pediatrics, Perinatology and Child Health 69
Countries citing papers authored by Phillip B. Stott
This map shows the geographic impact of Phillip B. Stott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip B. Stott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip B. Stott more than expected).
Fields of papers citing papers by Phillip B. Stott
This network shows the impact of papers produced by Phillip B. Stott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip B. Stott. The network helps show where Phillip B. Stott may publish in the future.
Co-authorship network of co-authors of Phillip B. Stott
This figure shows the co-authorship network connecting the top 25 collaborators of Phillip B. Stott. A scholar is included among the top collaborators of Phillip B. Stott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip B. Stott. Phillip B. Stott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 127 | |
| 2 | 8 | |
| 3 | 10 | |
| 4 | 139 | |
| 5 | 53 | |
| 6 | Cefuroxime axetil in the treatment of acute bronchitis in UK general practice. | 1 |
| 7 | 9 | |
| 8 | 1 | |
| 9 | Phase II study of thymosin fraction 5 in the treatment of metastatic renal cell carcinoma. | 3 |
| 10 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.